mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |